Parts Of Skin Care Patents Likely Invalid But No PTAB Review
The Patent Trial and Appeal Board refused Tuesday to review two DUSA Pharmaceuticals Inc. patents covering a skin treatment, despite finding that parts of the patents were likely invalid....To view the full article, register now.
Already a subscriber? Click here to view full article